Abstract
Contemporary clinical trials of heart failure with preserved ejection fraction (HFpEF) apply natriuretic peptide (NP) thresholds to identify patients who are more likely to have the disease of interest and to enrich the baseline risk of the enrolled cohort. To determine whether age, race/ethnicity, obesity, renal function, and atrial fibrillation (AF) affect the levels of NPs in HFpEF and whether the prognostic significance of NPs varies in these clinically important subgroups. This secondary analysis of the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist Trial (TOPCAT) evaluated the distribution and prognostic significance of NPs across 6 subgroups comprising 1057 adult patients (60%) in the Americas region of TOPCAT with symptomatic heart failure (HF) and a left ventricular ejection fraction of 45% or more with available NPs at baseline. Natriuretic peptides were log-transformed and standardized (expressed per 1 SD, z score) and assessed in 6 subgroups: age (cutoff, 70 years), black race, body mass index (BMI; calculated as weight in kilograms divided by height in meters squared; cutoff, 30 kg/m2), waist circumference (cutoff, 102 cm for men, 88 cm for women), estimated glomerular filtrati...Continue Reading
References
May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults
Jun 25, 2003·Circulation·Thomas J WangRamachandran S Vasan
Feb 11, 2004·Circulation·Thomas J WangRamachandran S Vasan
Jul 1, 2011·Circulation. Heart Failure·Inder S AnandPeter E Carson
Dec 6, 2011·American Heart Journal·Akshay S DesaiMarc A Pfeffer
Jun 5, 2013·Annals of Internal Medicine·Paul E Stevens, Adeera Levin
Apr 11, 2014·The New England Journal of Medicine·Bertram PittUNKNOWN TOPCAT Investigators
Nov 20, 2014·Circulation·Marc A PfefferBertram Pitt
May 23, 2015·Journal of the American Heart Association·Deepak K GuptaScott D Solomon
May 22, 2016·European Heart Journal·Piotr PonikowskiUNKNOWN ESC Scientific Document Group
Mar 28, 2017·Journal of the American Heart Association·Sara B SeidelmannScott D Solomon
Apr 1, 2017·JACC. Heart Failure·Inder S AnandScott D Solomon
Apr 28, 2017·Circulation·Sheryl L ChowUNKNOWN American Heart Association Clinical Pharmacology Committee of the Council on Clinical Cardiology; Council on Basic Cardiovas
Jul 1, 2017·JACC. Heart Failure·Scott D SolomonJohn J V McMurray
May 19, 2018·Journal of the American College of Cardiology·Milton Packer
Citations
Mar 16, 2019·Circulation. Heart Failure·Søren L KristensenJohn J V McMurray
Jun 22, 2019·Circulation. Heart Failure·Senthil SelvarajScott D Solomon
Jan 21, 2020·Circulation. Heart Failure·Peder L MyhreAkshay S Desai
Jan 30, 2020·Kardiologiia·Yu V MareevV Yu Mareev
Apr 16, 2020·European Journal of Heart Failure·Muhammad Shahzeb KhanJaved Butler
Dec 5, 2019·JAMA Network Open·Daniel N SilvermanMarkus Meyer
Jul 17, 2020·Frontiers in Physiology·Tara C HitzemanRobin M Shaw
May 31, 2019·International Journal of Molecular Sciences·Daniela Maria TanaseMariana Floria
Jul 25, 2019·European Journal of Heart Failure·Peder L MyhreScott D Solomon
Aug 25, 2020·European Journal of Heart Failure·Juan R ReyUNKNOWN CARD-COVID Investigators
Nov 16, 2020·JACC. Heart Failure·Peder L MyhreScott D Solomon
Nov 15, 2019·Journal of the American College of Cardiology·Muthiah VaduganathanScott D Solomon
Dec 4, 2020·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Lingyu XuUNKNOWN AB HEART Investigators
Mar 25, 2021·ESC Heart Failure·Mitsutaka NakashimaHiroshi Ito
Apr 29, 2021·Arquivos brasileiros de cardiologia·Devrim BozkurtSalih Kilic
Mar 17, 2020·JACC. Heart Failure·Nasrien E IbrahimJames L Januzzi